Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
Featured trial
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexipiprazole as Adjunctive Therapy in the Maintenance of Adults With Major Depressive Disorder

A study to compare the efficacy of brexpiprazole to placebo as adjunctive therapy to antidepressant therapy for the maintenance treatment in adults with major depressive disorder.  

depressive disorder
antidepressant therapy
  • 143 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole (1 - 3 mg/day) as Monotherapy or as Combination Therapy in the Treatment of Adults with Post-traumatic Stress Disorder

A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole (1 - 3 mg/day) as Monotherapy or as Combination Therapy in the Treatment of Adults with Post

  • 1451 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Study Seeking Patients with Post Traumatic Stress Disorder (PTSD)

Study Seeking Patients with Post Traumatic Stress Disorder (PTSD)

  • 1453 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Clinical study seeking patients with PTSD

Clinical study seeking patients with PTSD

  • 2438 views
  • 25 Mar, 2021
  • 1 location
Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia

Confirm the efficacy of the brexpiprazole QW formulation versus placebo for acute symptoms of schizophrenia

  • 1 views
  • 04 Oct, 2022
  • 1 location
Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

To evaluate the superiority of brexpiprazole 1 mg or 2 mg over placebo after a 10-week treatment regimen for agitation associated with dementia of the Alzheimer's type in patients who require

  • 8 views
  • 04 Oct, 2022
  • 1 location
Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD

This will be a 12-week, multicenter, randomized, double-blind trial evaluating the efficacy, safety, and tolerability of brexpiprazole + sertraline combination treatment in adult subjects with

sertraline
  • 39 views
  • 04 Oct, 2022
  • 1 location
Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder

This will be a 12-week, multicenter, randomized, double-blind trial evaluating the efficacy, safety, and tolerability of fixed-dose brexpiprazole + sertraline combination treatment in adult

sertraline
  • 36 views
  • 04 Oct, 2022
  • 1 location
Brexpiprazole Study

, heroin, or cannabis). Eighty patients will be randomly assigned to switch to brexpiprazole (the brexpiprazole group) or remain on the same antipsychotic treatment (the control group). The study will be

brexpiprazole
schizoaffective disorder
structured clinical interview
antipsychotics
substance use disorder
  • 136 views
  • 14 Jun, 2022
  • 3 locations
Brexpiprazole in Alcohol Use Disorder

replicated. A promising novel medication for AUD is brexpiprazole (BREX), a serotonin/dopamine activity modulator (SDAM). The investigators conducted a prior study in which the effects of another SDAM

psychiatric disorder
scid
functional magnetic resonance imaging
drug abuse
  • 388 views
  • 04 Oct, 2022
  • 1 location